Xanax Pulled From Shelves Due to Potential Contamination Risk

Photo: WLADIMIR BULGAR//Getty Images/Science Photo Library

A batch of the world’s most recognizable brand of anti-anxiety medication had the pharmaceutical company that manufactures it concerned enough to pull it from drugstore shelves.

CNN reports that Mylan Pharmaceuticals Inc. has recalled one group — or “lot,” as the company referred to it in its press release on Friday — of alprazolam, a drug commonly marketed under the brand name Xanax. The company attributed the recall to “the potential presence of foreign substance.” The press release states that, even if the “foreign material” is present, the “clinical impact … is expected to be rare, but the remote risk of infection to a patient cannot be ruled out.” Mylan says they have yet to receive a report of adverse effects due to the potentially compromised lot.

The voluntary recall includes “Alprazolam Tablets, USP C-IV 0.5 mg … packaged in bottles of 500 … distributed in the U.S. between July 2019 and August 2019.” The expiration date listed for this lot is September 2020. Mylan has not provided any additional information on the nature of the potential contamination, nor has the U.S. Food and Drug Administration.

The company’s announcement comes with directives for wholesalers and retailers of the drug to “immediately examine” their inventory, cease distribution of any recalled drugs, and notify people who are already in possession of these meds. Additionally, the company lists contact information for consumers who need to safety return the product.

In December, Mylan expanded its nationwide recall of some blood pressure meds, all of which contained Valsartan, after it found traces of the chemical N-nitrosodiethylamine (NDEA), which has been linked linked to cancer.

Xanax Pulled From Shelves Over Potential Contamination Risk